Market Cap

Amgen Market Capitalization:

Amgen Inc.

$141.72 Billion

USD as of April 1, 2022

business Amgen Company Profile

Amgen Main Stock Listing

show_chart NASDAQ: AMGN

Market capitalization history of Amgen

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of Amgen market cap

Date Market Cap YoY Change
Jan. 1, 2022 $129.30 B -1.89%
Jan. 1, 2021 $131.79 B -2.20%
Jan. 1, 2020 $134.76 B 30.06%
Jan. 1, 2019 $103.62 B 13.02%
Jan. 1, 2018 $91.68 B 21.91%
Jan. 1, 2017 $75.20 B -4.55%
Jan. 1, 2016 $78.79 B 1.27%
Jan. 1, 2015 $77.80 B 42.76%
Jan. 1, 2014 $54.50 B 33.33%
Jan. 1, 2013 $40.87 B 37.09%
Jan. 1, 2012 $29.82 B 18.89%
Jan. 1, 2011 $25.08 B -2.53%
Jan. 1, 2010 $25.73 B -3.35%
Jan. 1, 2009 $26.62 B 25.73%
Jan. 1, 2008 $21.17 B -31.90%
Jan. 1, 2007 $31.09 B -13.77%
Jan. 1, 2006 $36.06 B 23.61%
Jan. 1, 2005 $29.17 B 3.43%
Jan. 1, 2004 $28.20 B 28.40%
Jan. 1, 2003 $21.96 B -15.04%
Jan. 1, 2002 $25.85 B -13.62%
Jan. 1, 2001 $29.93 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Best-Selling Downloads - US

S&P 500 Companies Excel Download $29.90
Russell 3000 Companies Excel Download $99.90
580 Unicorn Startup Companies – Excel Spreadsheet $29.90

Save tens of hours in 2 minutes!

Company Description

Amgen Inc. is a multinational biotechnology and pharmaceutical company. It produces various drugs, including Neulasta, which prevents infections for patients undergoing cancer chemotherapy, Enbrel, a necrosis blocker for the treatment of autoimmune diseases. Focusing on molecular biology and biochemistry, Amgen aims at developing health care through recombinant DNA technology.

business Amgen Company Profile

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.